tiprankstipranks
Heron Therapeutics (HRTX)
NASDAQ:HRTX
US Market

Heron Therapeutics (HRTX) Income Statement

Compare
1,567 Followers

Heron Therapeutics Income Statement

Last quarter (Q4 2024), Heron Therapeutics's total revenue was $40.78M, an increase of 19.13% from the same quarter last year. In Q4, Heron Therapeutics's net income was $3.66M. See Heron Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 144.28M$ 127.04M$ 107.67M$ 86.35M$ 88.64M
Gross Profit
$ 105.64M$ 61.94M$ 52.80M$ 40.33M$ 52.45M
Operating Expenses
$ 117.17M$ 172.55M$ 227.46M$ 258.15M$ 280.61M
Depreciation and Amortization
$ 2.49M$ 2.90M$ 2.89M$ 3.02M$ 2.85M
EBITDA
$ -5.06M$ -103.79M$ -176.66M$ -215.25M$ -222.53M
Operating Income
$ -11.53M$ -110.61M$ -174.66M$ -217.83M$ -228.16M
Other Income/Expenses
$ -2.05M$ 56.00K$ -7.37M$ -2.85M$ 885.00K
Pretax Income
$ -13.58M$ -110.56M$ -182.02M$ -220.68M$ -227.28M
Net Income
$ -13.58M$ -110.56M$ -134.52M$ -217.66M$ -224.43M
Per Share Metrics
Basic EPS
$ -0.09$ -0.80$ -1.24$ -2.21$ -2.47
Diluted EPS
$ -0.09$ -0.80$ -1.24$ -2.21$ -2.47
Weighted Average Shares Outstanding
152.45M 138.13M 108.88M 98.47M 90.77M
Weighted Average Shares Outstanding (Diluted)
152.45M 138.13M 108.88M 98.47M 90.77M
Currency in USD

Heron Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis